Oxford Nanopore Technologies (LON:ONT - Get Free Report)'s stock had its "buy" rating reiterated by Berenberg Bank in a report released on Wednesday, LSE.Co.UK reports. They currently have a GBX 350 ($4.36) price target on the stock. Berenberg Bank's target price would indicate a potential upside of 253.89% from the stock's previous close.
Separately, Citigroup reiterated a "buy" rating and issued a GBX 210 ($2.61) target price on shares of Oxford Nanopore Technologies in a report on Friday, April 12th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of GBX 303.75 ($3.78).
Check Out Our Latest Research Report on Oxford Nanopore Technologies
Oxford Nanopore Technologies Trading Down 1.3 %
Oxford Nanopore Technologies stock traded down GBX 1.30 ($0.02) during trading on Wednesday, hitting GBX 98.90 ($1.23). The company had a trading volume of 2,078,486 shares, compared to its average volume of 884,834. Oxford Nanopore Technologies has a 1-year low of GBX 92.20 ($1.15) and a 1-year high of GBX 279 ($3.47). The company has a current ratio of 5.01, a quick ratio of 6.01 and a debt-to-equity ratio of 6.47. The company's 50 day simple moving average is GBX 133.17 and its 200-day simple moving average is GBX 169.54. The stock has a market cap of £850.50 million, a price-to-earnings ratio of -659.33 and a beta of 0.59.
Insider Buying and Selling at Oxford Nanopore Technologies
In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera purchased 39,196 shares of the firm's stock in a transaction on Wednesday, March 6th. The stock was bought at an average price of GBX 127 ($1.58) per share, with a total value of £49,778.92 ($61,968.03). Insiders acquired 39,421 shares of company stock valued at $5,007,852 in the last 90 days. Company insiders own 30.07% of the company's stock.
About Oxford Nanopore Technologies
(
Get Free Report)
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
Further Reading
Before you consider Oxford Nanopore Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.
While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
